510(k) Report

510(k) · Cleared

Cleared

Innovance D-Dimer, Model OPBP09

K093626510(k) TraditionalCleared Nov 29, 2010370-day reviewClass II21 CFR 864.7320

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Siemens Healthcare Diagnostics · DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control

Cleared on Nov 29, 2010 as substantially equivalent to K040882 (bioMerieux, Inc., 2004) after a 370-day review. Its family tree reaches back 4 generations to 1986. 2 later devices descend from it.

Decided
Nov 29, 2010
Review
370 days
Class
Class II
Product code
DAP
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K862156 (1986). 2 later devices descend from it, 2 citing it directly.

  1. Root · 4 generations backK862156 Asserachrom D-DI KitAmerican Bioproducts Co. · 1986
  2. 3 generations backK973819 Vidas D-Dimer (DD) AssayBiomerieux Vitek, Inc. · 1998
  3. 2 generations backK020810 Vidas D-Dimer New (DD2) Assay Model#30 442bioMerieux, Inc. · 2002
  4. 1 generation backK040882 Vidas D-Dimer Exclusion Assay, Model 30 442bioMerieux, Inc. · 2004
  5. This deviceK093626 Innovance D-Dimer, Model OPBP09Siemens Healthcare Diagnostics · 2010
  6. Descendant · cites it directly · 0 of its ownK253985 INNOVANCE® D-Dimer 2.0 (SMN 10873803)Siemens Healthcare Diagnostic Products GmbH · 2026
  7. Descendant · cites it directly · 0 of its ownK110303 Stratus CS Acute Care D-DimerSiemens Healthcare Diagnostics · 2011 · Recalled

Most influential descendants

Showing 2 of 2 · See all
  • K253985INNOVANCE® D-Dimer 2.0 (SMN 10873803)Siemens Healthcare Diagnostic Products GmbH · 2026 · cites it directly0descendants
  • K110303Stratus CS Acute Care D-DimerSiemens Healthcare Diagnostics · 2011 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K862156Asserachrom D-DI KitAmerican Bioproducts Co.1986—
−3K973819Vidas D-Dimer (DD) AssayBiomerieux Vitek, Inc.1998—
−2K020810Vidas D-Dimer New (DD2) Assay Model#30 442bioMerieux, Inc.2002—
−1K040882Vidas D-Dimer Exclusion Assay, Model 30 442bioMerieux, Inc.2004—
0 (this device)K093626Innovance D-Dimer, Model OPBP09Siemens Healthcare Diagnostics2010—
+1K253985INNOVANCE® D-Dimer 2.0 (SMN 10873803)Siemens Healthcare Diagnostic Products GmbH2026—
+1K110303Stratus CS Acute Care D-DimerSiemens Healthcare Diagnostics20111

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201110
202610
FIG. 1 — Lineage of K093626, 1986–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DAP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DAP device

  1. #1 K253985 INNOVANCE® D-Dimer 2.0 (SMN 10873803)score 13.0 · 5 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K040882Vidas D-Dimer Exclusion Assay, Model 30 442
Summary page 2
…dical device to which equivalence is claimed and comparison information: The INNOVANCE® 0-Dimer is substantially equivalent to the VIDAS® D-Dimer ExclusionTM (k040882) assay. The INNOVANCE® D-Dimer method, like the VIDAS® 0- Dimner ExclusionTM method, is intended for use in conjunction with…
bioMerieux, Inc.2004—

Also cleared against K040882: 8 other devices →

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K253985INNOVANCE® D-Dimer 2.0 (SMN 10873803)Siemens Healthcare Diagnostic Products GmbH20260
K110303Stratus CS Acute Care D-DimerSiemens Healthcare Diagnostics20110

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 24 years and passes through 4 companies; a new generation was cleared every 6.5 years on median.
  • None of the 4 ancestors has a recall.
  • Of its descendants, K253985 (Siemens Healthcare Diagnostic Products GmbH, 2026) has gone furthest, with 0 descendants of its own.
  • 8 other devices also cite its predicate K040882.

How does its category compare?

All DAP devices

DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · DAP

1in 2017

2007: 22008: 32009: 12010: 22011: 12012: 12014: 12015: 12016: 22017: 12026 (partial year): 1
2007high 3 (2008) · low 0 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DAP

127in 2008

2008: 127 days median
2007high 127 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DAP

2in 2025

2015: 12021: 12025: 2
2007high 2 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DAP

2in 2025

2007: 42008: 102009: 132010: 92011: 142012: 102013: 82014: 92015: 382016: 202017: 172018: 52019: 92020: 112021: 72022: 302023: 42024: 12025: 2
2007high 38 (2015) · low 1 (2024)2025

MAUDE reports naming product code DAP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—04
20083127010
20091—013
20102—09
20111—014
20121—010
20130—08
20141—09
20151—138
20162—020
20171—017
20180—05
20190—09
20200—011
20210—17
20220—030
20230—04
20240—01
20250—22
20261—0—

What is it indicated for?

For the quantitative determination of cross-linked fibrin degradation products (D-dimers) in human plasma on Siemens Healthcare Diagnostics and Sysmex® Coagulation Systems. The INNOVANCE® D-Dimer assay is intended for use in conjunction with a non-high clinical pretest probability (PTP) assessment model to exclude deep vein thrombosis (DVT) and pulmonary embolism (PE).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K093626: Innovance D-Dimer, Model OPBP09.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K093626

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026